NASDAQ:HQCL Hanwha Q CELLS (HQCL) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free HQCL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$9.82▼$9.8550-Day Range N/A52-Week Range$5.40▼$9.85Volume181,393 shsAverage Volume35,058 shsMarket Capitalization$817.76 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Hanwha Q CELLS alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Hanwha Q CELLS Stock (NASDAQ:HQCL)Hanwha Q CELLS Co., Ltd., a solar energy company, develops, manufactures, and sells solar cells and photovoltaic (PV) modules in South Korea, the United States, Europe, Japan, Australia, the People's Republic of China, India, Turkey, and internationally. Its principal products include PV cells, PV modules, silicon ingots, and silicon wafers. The company also develops and sells solar power projects; and offers engineering, procurement, and construction, as well as operation and management services. In addition, it offers services for the development and installation of ground-mounted and commercial rooftop PV systems. Hanwha Q CELLS Co., Ltd. serves utility companies and system integrators directly, as well as through third-party distributors. The company is headquartered in Seoul, South Korea. Hanwha Q CELLS Co., Ltd. is a subsidiary of Hanwha Solar Holdings Co., Ltd.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> HQCL Stock News HeadlinesApril 26, 2024 | msn.comHanwha Q Cells sued by US rival over alleged solar module patent infringementFebruary 14, 2024 | bbc.co.ukPlant and animal cellsApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 14, 2024 | bbc.co.ukTransport in cells - AQAJanuary 30, 2024 | wsj.comHanwha Corp.July 1, 2023 | forbes.comHanwha ChemicalJune 28, 2023 | wsj.comHanwha Aerospace Co. Ltd.April 15, 2023 | wsj.comHanwha Solutions Corp.April 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 26, 2023 | reuters.com009830.KSJanuary 11, 2023 | msn.comS.Korea's Hanwha Q Cells to invest $2.5 billion total in U.S. solar manufacturingOctober 14, 2022 | usatoday.comThese rats have human cells in their brains. They may help scientists understand autism and schizophrenia.October 14, 2022 | cbsnews.comScientists transplant human brain cells into the brains of baby ratsOctober 4, 2022 | investing.comHanwha Plus No 3 Special Purpose Acquisition Co (430460)See More Headlines Receive HQCL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hanwha Q CELLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2017Today4/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorOils/Energy Industry Semiconductors & Related Devices Sub-IndustryN/A Current SymbolNASDAQ:HQCL CUSIPN/A CIK1371541 Webwww.hanwha-qcells.com Phone82-2-7292-930xFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,400,000.00 Net Margins-10.51% Pretax MarginN/A Return on Equity-14.35% Return on Assets-2.39% Debt Debt-to-Equity Ratio2.60 Current Ratio1.00 Quick Ratio0.67 Sales & Book Value Annual Sales$2.18 billion Price / Sales0.38 Cash Flow$1.23 per share Price / Cash Flow8.02 Book Value$5.48 per share Price / Book1.79Miscellaneous Outstanding Shares83,190,000Free FloatN/AMarket Cap$817.76 million OptionableOptionable Beta0.45 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Jung Pyo Seo (Age 52)CFO & Director Mr. Hee Cheul Kim (Age 54)Chairman & CEO Dr. Daniel JeongGlobal Chief Technology OfficerMr. Paul W. Combs (Age 66)VP of Investor Relations Mr. Joo Yoon (Age 47)Head of Sales Planning, Product Management & Marketing and Director Key CompetitorsCanadian SolarNASDAQ:CSIQJinkoSolarNYSE:JKSSunPowerNASDAQ:SPWRShoals Technologies GroupNASDAQ:SHLSSolarEdge TechnologiesNASDAQ:SEDGView All Competitors HQCL Stock Analysis - Frequently Asked Questions How were Hanwha Q CELLS's earnings last quarter? Hanwha Q CELLS Co., Ltd. (NASDAQ:HQCL) issued its quarterly earnings results on Friday, November, 10th. The semiconductor company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.01. The semiconductor company had revenue of $543 million for the quarter, compared to analyst estimates of $564.60 million. Hanwha Q CELLS had a negative trailing twelve-month return on equity of 14.35% and a negative net margin of 10.51%. The company's revenue for the quarter was down 23.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.50 EPS. What other stocks do shareholders of Hanwha Q CELLS own? Based on aggregate information from My MarketBeat watchlists, some companies that other Hanwha Q CELLS investors own include Redfin (RDFN), SunPower (SPWR), Canadian Solar (CSIQ), Pfizer (PFE), Ayala Pharmaceuticals (ADXS), FuelCell Energy (FCEL), JinkoSolar (JKS), Netflix (NFLX), Alcoa (AA) and Bank of America (BAC). This page (NASDAQ:HQCL) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hanwha Q CELLS Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
